Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal
Portfolio Pulse from
Elanco's Zenrelia™ (ilunocitinib tablets) is highlighted in a study published in Veterinary Dermatology, comparing its effectiveness to Apoquel® for treating allergic dogs.
January 27, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Elanco's Zenrelia™ is featured in a study comparing its effectiveness to Apoquel® for treating allergic dogs, potentially boosting its market position.
The study published in a reputable journal highlights Zenrelia's effectiveness, which could enhance Elanco's product portfolio and market share in veterinary dermatology.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80